[1]
Kim, Y. and Shin, D. 2023. CLINICAL RESULTS OF LONG-TERM LOBEGLITAZONE ADD-ON THERAPY IN TYPE 2 DIABETES. Journal of the ASEAN Federation of Endocrine Societies. 38, S3 (Nov. 2023), 71–72.